Synthesis of alkyne- and azide-functionalised aziridine and epoxide carbocycles for development of selective glucuronidase mechanism-based inhibitors

10 April 2024, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Heparanase (HPSE) is an endo-acting beta-glucuronidase and the only known enzyme responsible for the regulation of extracellular heparan sulfate (HS) structures, a glycosaminoglycan (GAG) occurring in conjugation with a protein class called heparan sulfate proteoglycans (HSPGs) in the extracellular matrix (ECM). The enzyme is found to be significantly upregulated in aggressive cancer types aiding cell proliferation by increased degradation of HS. Inhibition of HPSE reduces cancer growth making it an interesting druggable target for cancer treatment and diagnostics. Only few of the known efficient HPSE inhibitors have progressed through clinical studies and none of them has been approved yet. We here present the synthesis of three cyclophellitol scaffolds, based on known mechanism-based inhibitors of HSPE. These novel scaffolds are amenable to facile elaboration via copper-catalysed azide-alkyne cycloadditions to aid in exploring the structure-activity relationship for selective inhibitors of HSPE.

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.